D-0233-2015 Class II Terminated
FDA drug recall D-0233-2015 was initiated by Actavis Inc on August 25, 2014 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated March 21, 2018). Affected quantity: 46,676 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- November 5, 2014
- Initiation Date
- August 25, 2014
- Termination Date
- March 21, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 46,676 cartons
Product Description
Vancomycin Hydrochloride Capsule, USP, 250 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3561-15 UPC 3-3-0591356115-1
Reason for Recall
Subpotent Drug
Distribution Pattern
Nationwide
Code Information
3101178, exp Aug 2014, 3104318, exp Aug 2014, 3104319, exp Oct 2014, 3104889, exp Oct 2014, 3104891, exp Oct 2014, 3104893, exp Oct 2014, and 3106651, exp Dec 2014